Hence, there is increasing interest in exploring the potential role of angiotensin-converting enzyme inhibitors (ACEis) and beta-blockers (BBs), drugs used for chronic cardiovascular disease, in reducing pneumonia severity [3,9]. The gene discussed is ACE; the disease is susceptibility to pneumonia measurement.